Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses

European Journal of Immunology

Volumn 29, Issue 12, 1999, Pages 3867-3876

  Prigent, Philippe ^a   El Mir, Samir ^a   Dréano, Michel ^b   Triebel, Frédéric ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Serono International SA   (Switzerland)

Author keywords

Cytotoxicity; Dendritic cell; MHC; Tumor immunity; Vaccination

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR REGRESSION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, NEOPLASM; CELL COMMUNICATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; MICE; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0032711858     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199912)29:12<3867::AID-IMMU3867>3.0.CO;2-E     Document Type: Article

References (29)

1. Restifo, N. P. and Wunderlich, J. R., Biology of cellular immune responses. In DeVita, V. T., Jr., Hellman, S. and Rosenberg, S. A. (Eds) Biological Therapy of Cancer. Lippincott, Philadelphia 1995, pp 3-37.
2. Pardoll, D. M., Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 1995. 13: 399-415.
3. Triebel, F., Jitsukawa, S., Baixeras, E., Roman-Roman, S., Genevée, C., Viegas-Pequignot, E. and Hercend, T., LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 1990. 171: 1393-1405.
4. Bruniquel, D., Borie, N. and Triebel, F., Genomic organization of the human LAG-3/CD4 locus, Immunogenetics 1997. 47: 96-98.
5. Baixeras, E., Huard, B., Miossec, C., Jitsukawa, S., Martin, M., Hercend, T., Auffray, C., Triebel, F. and Piatier-Tonneau, D., Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J. Exp. Med. 1992. 176: 327-337.
6. + T cell clone response following LAG-3 binding. Eur. J. Immunol. 1996. 26: 1180-1186.
7. Huard, B., Prigent, P., Tournier, M., Bruniquel, D. and Triebel, F., CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation genes-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 1995. 25: 2718-2721.
8. Huard, B., Mastrangeli, R., Prigent, P., Bruniquel, D., Donini, S., El-Tayar, N., Maigret, B., Dreano, M. and Triebel, F., Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Proc. Natl. Acad. Sci. USA 1997. 94: 5744-5749.
9. Hannier, S., Tournier, M., Bismuth, G. and Triebel, F., CD3/TCR complex-associated LAG-3 molecules inhibit CD3/TCR signaling. J. Immunol. 1998. 161: 4058-4065.
10. Huard, B., Gaulard, P., Faure, F., Hercend, T. and Triebel, F., Cellular expression and tissue distribution of the human LAG-3-encoded protein, a MHC class II ligand. Immunogenetics 1994. 39: 13-217.
11. Sakihama, T., Smolyar, A. and Reinherz, E. L., Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 1995. 92: 6444-6448.
12. Li, S., Satoh, T., Korngold, R. and Huang, Z., CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design. Immunol. Today 1998. 19: 455-462.
13. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
14. Wade, W. F., Davoust, J., Salamero, J., Andre, P., Watts, T. H. and Gambier, J. C., Structural compartmentalization of MHC class II signaling function. Immunol. Today 1993. 14: 539-541.
15. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N. and Schuler, G., High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 1996. 184: 741-746.
16. Avice, M. N., Sarfati, M., Triebel, F., Delespesse, G. and Demeure, C. E., LAG-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells. J. Immunol. 1999. 162: 2748-2753.
17. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. and Levitsky, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994. 264: 961-965.
18. Cella, M., Sallusto, F. and Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997. 9: 10-16.
19. Fuchs, E. J. and Matzinger, P., Is cancer dangerous to the immune system? Semin. Immunol. 1996. 8: 271-280.
20. Chen, W., Syldath, U., Bellmann, K., Burkart, V. and Kolb, H., Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 1999. 162:3212-3219.
21. Krieg, A. M., Love-Homan, L., Yi, A. K. and Harty, J. T., CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 1998. 161: 2428-2434.
22. Lasarte, J. J., Corrales, F. J., Casares, N., López-Díaz de Cerio, A., Qian, C., Xie, X., Borrás-Cuesta, F. and Prieto, J., Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide. J. Immunol. 1999. 162: 5270-5277.
23. + T cells are associated with IFN-γ production. FASEB J. 1996. 10: 769-776.
24. Bruniquel, D., Borie, N., Hannier, S. and Triebel, F., Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II. Immunogenetics 1998. 48: 116-124.
25. Cavallo, F., Pierro, F. D., Giovarelli, M., Gulino, A., Vacca, A., Stoppacciaro, A., Forni, M., Modesti, A. and Forni, G., Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res. 1993. 53: 5067-5070.
26. Van den Eynde, B. J. and van der Bruggen, P., T cell defined tumor antigens. Curr. Opin. Immunol. 1997. 9: 684-693.
27. Schuler, G. and Steinman, R. M., Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 1997. 186: 1183-1187.
28. Takebe, Y., Seiki, M., Fujisawa, J. I., Hoy, P., Yokota, K., Arai, K. I., Yoshida, M. and Aral, N., SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 1988. 8: 466-472.
29. McKinney, M. M. and Parkinson, A., A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J. Immunol. Methods 1987. 96: 271-273.